Editorial: Factor VIII inhibitors.
D000906:Antibodies; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D005164:Factor IX / Q000627:therapeutic use; D005167:Factor VII / Q000627:therapeutic use; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D005170:Factor X / Q000627:therapeutic use; D005172:Factor XI / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D011516:Prothrombin / Q000627:therapeutic use
D000906:Antibodies; D001779:Blood Coagulation Factors; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005172:Factor XI